Global Romiplostim Market Growth (Status and Outlook) 2022-2028
- LP 4798519
- 62 Pages
- January 2022
- Pharmaceuticals
The United States Romiplostim market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Romiplostim market, reaching US$ million by the year 2028. As for the Europe Romiplostim landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Romiplostim players cover AMGEN, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Romiplostim market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
250 μg/0.5 mL
500 μg/1 mL
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adults
Pediatric patients
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AMGEN
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Romiplostim Market Size 2017-2028
2.1.2 Romiplostim Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Romiplostim Segment by Type
2.2.1 250 μg/0.5 mL
2.2.2 500 μg/1 mL
2.3 Romiplostim Market Size by Type
2.3.1 Romiplostim Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Romiplostim Market Size Market Share by Type (2017-2022)
2.4 Romiplostim Segment by Application
2.4.1 Adults
2.4.2 Pediatric patients
2.5 Romiplostim Market Size by Application
2.5.1 Romiplostim Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Romiplostim Market Size Market Share by Application (2017-2022)
3 Romiplostim Market Size by Player
3.1 Romiplostim Market Size Market Share by Players
3.1.1 Global Romiplostim Revenue by Players (2020-2022)
3.1.2 Global Romiplostim Revenue Market Share by Players (2020-2022)
3.2 Global Romiplostim Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Romiplostim by Regions
4.1 Romiplostim Market Size by Regions (2017-2022)
4.2 Americas Romiplostim Market Size Growth (2017-2022)
4.3 APAC Romiplostim Market Size Growth (2017-2022)
4.4 Europe Romiplostim Market Size Growth (2017-2022)
4.5 Middle East & Africa Romiplostim Market Size Growth (2017-2022)
5 Americas
5.1 Americas Romiplostim Market Size by Country (2017-2022)
5.2 Americas Romiplostim Market Size by Type (2017-2022)
5.3 Americas Romiplostim Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Romiplostim Market Size by Region (2017-2022)
6.2 APAC Romiplostim Market Size by Type (2017-2022)
6.3 APAC Romiplostim Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Romiplostim by Country (2017-2022)
7.2 Europe Romiplostim Market Size by Type (2017-2022)
7.3 Europe Romiplostim Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Romiplostim by Region (2017-2022)
8.2 Middle East & Africa Romiplostim Market Size by Type (2017-2022)
8.3 Middle East & Africa Romiplostim Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Romiplostim Market Forecast
10.1 Global Romiplostim Forecast by Regions (2023-2028)
10.1.1 Global Romiplostim Forecast by Regions (2023-2028)
10.1.2 Americas Romiplostim Forecast
10.1.3 APAC Romiplostim Forecast
10.1.4 Europe Romiplostim Forecast
10.1.5 Middle East & Africa Romiplostim Forecast
10.2 Americas Romiplostim Forecast by Country (2023-2028)
10.2.1 United States Romiplostim Market Forecast
10.2.2 Canada Romiplostim Market Forecast
10.2.3 Mexico Romiplostim Market Forecast
10.2.4 Brazil Romiplostim Market Forecast
10.3 APAC Romiplostim Forecast by Region (2023-2028)
10.3.1 China Romiplostim Market Forecast
10.3.2 Japan Romiplostim Market Forecast
10.3.3 Korea Romiplostim Market Forecast
10.3.4 Southeast Asia Romiplostim Market Forecast
10.3.5 India Romiplostim Market Forecast
10.3.6 Australia Romiplostim Market Forecast
10.4 Europe Romiplostim Forecast by Country (2023-2028)
10.4.1 Germany Romiplostim Market Forecast
10.4.2 France Romiplostim Market Forecast
10.4.3 UK Romiplostim Market Forecast
10.4.4 Italy Romiplostim Market Forecast
10.4.5 Russia Romiplostim Market Forecast
10.5 Middle East & Africa Romiplostim Forecast by Region (2023-2028)
10.5.1 Egypt Romiplostim Market Forecast
10.5.2 South Africa Romiplostim Market Forecast
10.5.3 Israel Romiplostim Market Forecast
10.5.4 Turkey Romiplostim Market Forecast
10.5.5 GCC Countries Romiplostim Market Forecast
10.6 Global Romiplostim Forecast by Type (2023-2028)
10.7 Global Romiplostim Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AMGEN
11.1.1 AMGEN Company Information
11.1.2 AMGEN Romiplostim Product Offered
11.1.3 AMGEN Romiplostim Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AMGEN Main Business Overview
11.1.5 AMGEN Latest Developments
12 Research Findings and Conclusion
Table 1. Romiplostim Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 250 μg/0.5 mL
Table 3. Major Players of 500 μg/1 mL
Table 4. Romiplostim Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Romiplostim Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Romiplostim Market Size Market Share by Type (2017-2022)
Table 7. Romiplostim Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Romiplostim Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Romiplostim Market Size Market Share by Application (2017-2022)
Table 10. Global Romiplostim Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Romiplostim Revenue Market Share by Player (2020-2022)
Table 12. Romiplostim Key Players Head office and Products Offered
Table 13. Romiplostim Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Romiplostim Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Romiplostim Market Size Market Share by Regions (2017-2022)
Table 18. Americas Romiplostim Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Romiplostim Market Size Market Share by Country (2017-2022)
Table 20. Americas Romiplostim Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Romiplostim Market Size Market Share by Type (2017-2022)
Table 22. Americas Romiplostim Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Romiplostim Market Size Market Share by Application (2017-2022)
Table 24. APAC Romiplostim Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Romiplostim Market Size Market Share by Region (2017-2022)
Table 26. APAC Romiplostim Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Romiplostim Market Size Market Share by Type (2017-2022)
Table 28. APAC Romiplostim Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Romiplostim Market Size Market Share by Application (2017-2022)
Table 30. Europe Romiplostim Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Romiplostim Market Size Market Share by Country (2017-2022)
Table 32. Europe Romiplostim Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Romiplostim Market Size Market Share by Type (2017-2022)
Table 34. Europe Romiplostim Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Romiplostim Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Romiplostim Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Romiplostim Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Romiplostim Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Romiplostim Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Romiplostim Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Romiplostim Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Romiplostim
Table 43. Key Market Challenges & Risks of Romiplostim
Table 44. Key Industry Trends of Romiplostim
Table 45. Global Romiplostim Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Romiplostim Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Romiplostim Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Romiplostim Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Romiplostim Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Romiplostim Market Size Market Share Forecast by Application (2023-2028)
Table 51. AMGEN Details, Company Type, Romiplostim Area Served and Its Competitors
Table 52. AMGEN Romiplostim Product Offered
Table 53. AMGEN Romiplostim Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AMGEN Main Business
Table 55. AMGEN Latest Developments
List of Figures
Figure 1. Romiplostim Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Romiplostim Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Romiplostim Market Size Market Share by Type in 2021
Figure 7. Romiplostim in Adults
Figure 8. Global Romiplostim Market: Adults (2017-2022) & ($ Millions)
Figure 9. Romiplostim in Pediatric patients
Figure 10. Global Romiplostim Market: Pediatric patients (2017-2022) & ($ Millions)
Figure 11. Global Romiplostim Market Size Market Share by Application in 2021
Figure 12. Global Romiplostim Revenue Market Share by Player in 2021
Figure 13. Global Romiplostim Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Romiplostim Market Size 2017-2022 ($ Millions)
Figure 15. APAC Romiplostim Market Size 2017-2022 ($ Millions)
Figure 16. Europe Romiplostim Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Romiplostim Market Size 2017-2022 ($ Millions)
Figure 18. Americas Romiplostim Value Market Share by Country in 2021
Figure 19. Americas Romiplostim Consumption Market Share by Type in 2021
Figure 20. Americas Romiplostim Market Size Market Share by Application in 2021
Figure 21. United States Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Romiplostim Market Size Market Share by Region in 2021
Figure 26. APAC Romiplostim Market Size Market Share by Application in 2021
Figure 27. China Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Romiplostim Market Size Market Share by Country in 2021
Figure 34. Europe Romiplostim Market Size Market Share by Type in 2021
Figure 35. Europe Romiplostim Market Size Market Share by Application in 2021
Figure 36. Germany Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Romiplostim Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Romiplostim Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Romiplostim Market Size Market Share by Application in 2021
Figure 44. Egypt Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Romiplostim Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Romiplostim Market Size 2023-2028 ($ Millions)
Figure 50. APAC Romiplostim Market Size 2023-2028 ($ Millions)
Figure 51. Europe Romiplostim Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Romiplostim Market Size 2023-2028 ($ Millions)
Figure 53. United States Romiplostim Market Size 2023-2028 ($ Millions)
Figure 54. Canada Romiplostim Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Romiplostim Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Romiplostim Market Size 2023-2028 ($ Millions)
Figure 57. China Romiplostim Market Size 2023-2028 ($ Millions)
Figure 58. Japan Romiplostim Market Size 2023-2028 ($ Millions)
Figure 59. Korea Romiplostim Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Romiplostim Market Size 2023-2028 ($ Millions)
Figure 61. India Romiplostim Market Size 2023-2028 ($ Millions)
Figure 62. Australia Romiplostim Market Size 2023-2028 ($ Millions)
Figure 63. Germany Romiplostim Market Size 2023-2028 ($ Millions)
Figure 64. France Romiplostim Market Size 2023-2028 ($ Millions)
Figure 65. UK Romiplostim Market Size 2023-2028 ($ Millions)
Figure 66. Italy Romiplostim Market Size 2023-2028 ($ Millions)
Figure 67. Russia Romiplostim Market Size 2023-2028 ($ Millions)
Figure 68. Spain Romiplostim Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Romiplostim Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Romiplostim Market Size 2023-2028 ($ Millions)
Figure 71. Israel Romiplostim Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Romiplostim Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Romiplostim Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
